Back
Kymera Therapeutics Stock Price Chart
Potential crash warning signs flashing again on my charts
Here's my #1 indicator to try out now.
Buy
54
KYMR
Kymera Therapeutics
Last Price:
46.22
Seasonality Move:
17.96%
7 Day Trial
ALL ACCESS PASS
$
7
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.- The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
Kymera Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.31 | Sell |
| 20-day SMA: | 45.94 | Sell |
| 50-day SMA: | 42.33 | Buy |
| 200-day SMA: | 35.31 | Buy |
| 8-day EMA: | 46.68 | Sell |
| 20-day EMA: | 45.92 | Sell |
| 50-day EMA: | 42.99 | Buy |
| 200-day EMA: | 35.91 | Buy |
Kymera Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 50.68 | Buy |
| Chaikin Money Flow: | -64772 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.03 - 47.91) | Buy |
| Bollinger Bands (100): | (32.55 - 44.13) | Buy |
Kymera Therapeutics Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Kymera Therapeutics Stock
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 45.40 while KYMR 8-day simple moving average is 47.31, which is a Sell signal.
- The stock price of KYMR is 45.40 while Kymera Therapeutics 20-day SMA is 45.94, which makes it a Sell.
- Kymera Therapeutics 50-day simple moving average is 42.33 while KYMR share price is 45.40, making it a Buy technically.
- KYMR stock price is 45.40 and Kymera Therapeutics 200-day simple moving average is 35.31, creating a Buy signal.
KYMR Technical Analysis vs Fundamental Analysis
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy or a Sell?
-
Kymera Therapeutics stock is rated a Buy
The current Kymera Therapeutics [KYMR] share price is $45.40. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Kymera Therapeutics Stock Info
Market Cap:
2.8B
Price in USD:
45.40
Share Volume:
183.98K
Kymera Therapeutics 52-Week Range
52-Week High:
50.19
52-Week Low:
9.60
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Kymera Therapeutics Share Price Forecast
-
What is the Kymera Therapeutics stock price today?
The Kymera Therapeutics stock price is 45.40 USD today. -
Will KYMR stock go up or go down?
Kymera Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Kymera Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kymera Therapeutics is not overvalued.
Is Kymera Therapeutics Stock a Buy?
- Kymera Therapeutics share price is 45.40 while KYMR 8-day exponential moving average is 46.68, which is a Sell signal.
- The stock price of KYMR is 45.40 while Kymera Therapeutics 20-day EMA is 45.92, which makes it a Sell.
- Kymera Therapeutics 50-day exponential moving average is 42.99 while KYMR share price is 45.40, making it a Buy technically.
- KYMR stock price is 45.40 and Kymera Therapeutics 200-day simple moving average is 35.91, creating a Buy signal.
Fundamental Analysis of Kymera Therapeutics
Is Kymera Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Technical Analysis of Kymera Therapeutics
Should I short Kymera Therapeutics stock?
- KYMR Moving Average Covergence Divergence (MACD) indicator is 1.29, suggesting Kymera Therapeutics is a Buy
- Kymera Therapeutics Relative Strength Index (RSI) is 50.68, which suggest Kymera Therapeutics is overbought
- The Bollinger Bands (25) for Kymera Therapeutics is (42.03 - 47.91), which suggest Kymera Therapeutics is a Buy
- The Bollinger Bands (100) for Kymera Therapeutics is (32.55 - 44.13), which suggest Kymera Therapeutics is a Buy
* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.